Early Limb Rehabilitation Therapy Within 48 h of Acute Stroke Onset(ERTAS)

China Medical University

Status: Completed

Conditions: Time of First Rehabilitation Therapy

Treatments: Behavioral: stroke rehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT02718534

ERTAS

LNCCC-D12-2015 (Other Grant/Funding Number)

Details and patient eligibility

About

This study aimed to evaluate effectiveness of initial limb rehabilitation compare therapy took place within 48h with therapy took place after 48h for patients with stroke (modified Rankin Scale Score 3-4).

Full description

Early rehabilitation after stroke is thought to contribute to the effects of stroke-unit care. However, time of initial rehabilitation therapy is poorly defined and not underpinned by strong evidence in patients with stroke (modified Rankin Scale Score 3-4). The investigators do this parallel-group, single-blind, randomized controlled trial in shengjing hospital of China Medical University. Participants (aged≥18 years) with ischaemic or haemorrhagic stroke, first or recurrent, who meet physiological criteria are randomly assigned (1:1), to receive usual stroke therapy. Treatment with recombinant tissue plasminogen activator is allowed. Randomisation is stratified by study site and stroke severity. The primary outcome was a outcome 3 months after stroke, defined as a modified Rankin Scale score of 3-4. The investigators do analysis on an intention-to-treat basis.

Enrollment: 120 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients were diagnosed acute stroke within 24h onset. Head CT or MRI scans were confirmed the diagnosed.
2. The age was from 18 to 75 years old.
3. Temperature ≤38.0℃，Pulse rate 60-100bpm，Respiratory rate≤24 bpm，systolic blood pressure≤220mmHg.
4. Glasgow score: 9-14.
5. Acute Physiology and Chronic Health Evaluation(APACHE Ⅱ)score: ≤17.
6. National Institutes of Health Stroke Scale (NIHSS)score: <16. (Upper and lower extremity motor function item score<8).
7. Modified Rankin Scale score:3-4.
8. There were no serious diseases before, such as heart, liver, kidney and lung diseases.
9. Patients themselves or their nominated representative sign the informed consent form.

Exclusion criteria

1. There were unstable vital sign. There were serious organic dysfunction (heart, liver, kidney or lung).
2. Patients with transient ischemic attack.
3. Patients with subarachnoid haemorrhage.
4. Patients with haemorrhage were documented immediate surgery.
5. Pregnancy patients with stroke.
6. During the course of the project, major diseases took place (such as, myocardial infarction, gastrointestinal bleeding, respiratory failure, pulmonary embolism, deep vein thrombosis).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

120 participants in 2 patient groups

ERTAS-1

Experimental group

Description:

first limb rehabilitation therapy took place within 48h for patients with acute stroke (modified Rankin Scale Score 3-4)

Treatment:

Behavioral: stroke rehabilitation

ERTAS-2

Active Comparator group

Description:

first limb rehabilitation therapy took place after 48h for patients with acute stroke (modified Rankin Scale Score 3-4)

Treatment:

Behavioral: stroke rehabilitation